Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.

Gressot LV, Doucette T, Yang Y, Fuller GN, Manyam G, Rao A, Latha K, Rao G.

Oncotarget. 2017 Feb 21;8(8):12695-12704. doi: 10.18632/oncotarget.8657.

2.

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.

Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, Wang YA, Hu J, Bögler O.

J Transl Med. 2016 Feb 9;14:46. doi: 10.1186/s12967-016-0803-2.

3.

Perinatal Domoic Acid as a Neuroteratogen.

Doucette TA, Andrew Tasker R.

Curr Top Behav Neurosci. 2016;29:87-110. doi: 10.1007/7854_2015_417. Review.

PMID:
26695171
4.

Alterations to prepulse inhibition magnitude and latency in adult rats following neonatal treatment with domoic acid and social isolation rearing.

Marriott AL, Tasker RA, Ryan CL, Doucette TA.

Behav Brain Res. 2016 Feb 1;298(Pt B):310-7. doi: 10.1016/j.bbr.2015.11.009. Epub 2015 Nov 15.

PMID:
26590368
5.

Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.

Gressot LV, Doucette TA, Yang Y, Fuller GN, Heimberger AB, Bögler O, Rao A, Latha K, Rao G.

Int J Cancer. 2015 May 1;136(9):2047-54. doi: 10.1002/ijc.29264. Epub 2014 Oct 23.

6.

Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.

Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB.

J Natl Cancer Inst. 2014 Jun 28;106(8). pii: dju162. doi: 10.1093/jnci/dju162. Print 2014 Aug.

7.

Neonatal domoic acid abolishes latent inhibition in male but not female rats and has differential interactions with social isolation.

Marriott AL, Tasker RA, Ryan CL, Doucette TA.

Neurosci Lett. 2014 Aug 22;578:22-6. doi: 10.1016/j.neulet.2014.06.025. Epub 2014 Jun 19.

PMID:
24954074
8.

Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.

Doucette T, Latha K, Yang Y, Fuller GN, Rao A, Rao G.

Neuro Oncol. 2014 Sep;16(9):1220-8. doi: 10.1093/neuonc/nou034. Epub 2014 Mar 27.

9.

Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Doucette T, Rao G, Rao A, Shen L, Aldape K, Wei J, Dziurzynski K, Gilbert M, Heimberger AB.

Cancer Immunol Res. 2013 Aug;1(2):112-22. doi: 10.1158/2326-6066.CIR-13-0028.

10.

Voluntary forced use of the impaired limb following stroke facilitates functional recovery in the rat.

Livingston-Thomas JM, McGuire EP, Doucette TA, Tasker RA.

Behav Brain Res. 2014 Mar 15;261:210-9. doi: 10.1016/j.bbr.2013.12.032. Epub 2013 Dec 31.

PMID:
24388978
11.

miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB.

Cancer Res. 2013 Jul 1;73(13):3913-26. doi: 10.1158/0008-5472.CAN-12-4318. Epub 2013 May 1.

12.

A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic stroke.

Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA.

Acta Pharmacol Sin. 2013 Jan;34(1):104-12. doi: 10.1038/aps.2012.106. Epub 2012 Oct 29.

13.

Neonatal domoic acid treatment produces alterations to prepulse inhibition and latent inhibition in adult rats.

Marriott AL, Ryan CL, Doucette TA.

Pharmacol Biochem Behav. 2012 Dec;103(2):338-44. doi: 10.1016/j.pbb.2012.08.022. Epub 2012 Sep 7.

PMID:
22981693
14.

Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.

Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G.

Neuro Oncol. 2012 Sep;14(9):1136-45. doi: 10.1093/neuonc/nos139. Epub 2012 Jun 29.

15.

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.

Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, Sulman EP, Lang FF, Rao G, Copray S, Vaillant BD, Aldape KD.

Genes Dev. 2011 Dec 15;25(24):2594-609. doi: 10.1101/gad.176800.111.

16.

WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.

Doucette TA, Yang Y, Pedone C, Kim JY, Dubuc A, Northcott PD, Taylor MD, Fults DW, Rao G.

Neurosurgery. 2012 Apr;70(4):1003-10; discussion 1010. doi: 10.1227/NEU.0b013e31823e5332.

17.

B-cell lymphoma-2 promotes malignant progression in glioma.

Doucette TA, Rao G.

Clin Neurosurg. 2011;58:149-54. No abstract available.

PMID:
21916141
18.

Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.

Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN, Qiao W, Zhang W, Lang FF.

Neoplasia. 2011 Aug;13(8):716-25.

19.

Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.

Doucette T, Yang Y, Zhang W, Fuller GN, Suki D, Fults DW, Rao G.

Int J Cancer. 2011 Nov 1;129(9):2093-103. doi: 10.1002/ijc.25869. Epub 2011 Mar 4.

20.

Altered social interaction in adult rats following neonatal treatment with domoic acid.

Ryan CL, Robbins MA, Smith MT, Gallant IC, Adams-Marriott AL, Doucette TA.

Physiol Behav. 2011 Mar 1;102(3-4):291-5. doi: 10.1016/j.physbeh.2010.11.020. Epub 2010 Nov 23.

PMID:
21108956
21.

Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger AB.

Clin Cancer Res. 2010 Dec 1;16(23):5722-33. doi: 10.1158/1078-0432.CCR-10-1693. Epub 2010 Oct 4.

22.

Persistent changes in learning and memory in rats following neonatal treatment with domoic acid.

Adams AL, Doucette TA, James R, Ryan CL.

Physiol Behav. 2009 Mar 23;96(4-5):505-12. doi: 10.1016/j.physbeh.2008.11.019. Epub 2008 Dec 14.

PMID:
19146865
23.

Effects of estrous stage and time of day on prepulse inhibition in female rats.

Adams AL, Hudson A, Ryan CL, Doucette TA.

J Neurosci Methods. 2008 Aug 30;173(2):295-8. doi: 10.1016/j.jneumeth.2008.06.014. Epub 2008 Jun 25.

PMID:
18621080
24.

Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.

Sun HS, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, Ryan CL, Bernard PB, Lau A, Forder JP, Salter MW, Wang YT, Tasker RA, Tymianski M.

Stroke. 2008 Sep;39(9):2544-53. doi: 10.1161/STROKEAHA.107.506048. Epub 2008 Jul 10.

25.

Altered responses to novelty and drug reinforcement in adult rats treated neonatally with domoic acid.

Burt MA, Ryan CL, Doucette TA.

Physiol Behav. 2008 Jan 28;93(1-2):327-36. Epub 2007 Sep 25.

PMID:
17980392
26.

Altered pre-pulse inhibition in adult rats treated neonatally with domoic acid.

Adams AL, Doucette TA, Ryan CL.

Amino Acids. 2008 Jun;35(1):157-60. Epub 2007 Nov 2.

PMID:
17973071
27.

Low dose domoic acid in neonatal rats abolishes nicotine induced conditioned place preference during late adolescence.

Burt MA, Ryan CL, Doucette TA.

Amino Acids. 2008 Jun;35(1):247-9. Epub 2007 Aug 15.

PMID:
17701097
28.

Gender-based changes in cognition and emotionality in a new rat model of epilepsy.

Doucette TA, Ryan CL, Tasker RA.

Amino Acids. 2007;32(3):317-22. Epub 2006 Oct 27.

PMID:
17068662
29.

An improved post-operative care protocol allows detection of long-term functional deficits following MCAo surgery in rats.

Ryan CL, Doucette TA, Gill DA, Langdon KD, Liu Y, Perry MA, Tasker RA.

J Neurosci Methods. 2006 Jun 30;154(1-2):30-7. Epub 2006 Jan 19.

PMID:
16423407
30.

NMDA receptor involvement in the effects of low dose domoic acid in neonatal rats.

Tasker RA, Perry MA, Doucette TA, Ryan CL.

Amino Acids. 2005 Mar;28(2):193-6. Epub 2005 Feb 18.

PMID:
15714252
31.

Low doses of domoic acid during postnatal development produce permanent changes in rat behaviour and hippocampal morphology.

Doucette TA, Bernard PB, Husum H, Perry MA, Ryan CL, Tasker RA.

Neurotox Res. 2004;6(7-8):555-63.

PMID:
15639787
32.

Axial and rotational alignment of the leg.

Alizadeh RI, Eckhoff DG, Samson MM, Doucette TK, Hogan CA, Bach JM.

Biomed Sci Instrum. 2004;40:290-6.

PMID:
15133973
33.

Low doses of non-NMDA glutamate receptor agonists alter neurobehavioural development in the rat.

Doucette TA, Bernard PB, Yuill PC, Tasker RA, Ryan CL.

Neurotoxicol Teratol. 2003 Jul-Aug;25(4):473-9.

PMID:
12798964
34.

Comparison of the in vitro and in vivo neurotoxicity of three new sources of kainic acid.

Tasker RA, Bernard PB, Doucette TA, Kerr DS, Zabidin Y, Alvarez-Fernandez L, Fernandez-Maroto B, Fernandez-Sanchez MT, Novelli A.

Amino Acids. 2002;23(1-3):45-54.

PMID:
12373517
35.

Use of osmotic minipumps for sustained drug delivery in rat pups: effects on physical and neurobehavioural development.

Doucette TA, Ryan CL, Tasker RA.

Physiol Behav. 2000 Oct 1-15;71(1-2):207-12.

PMID:
11134704
36.

Comparative behavioural toxicity of domoic acid and kainic acid in neonatal rats.

Doucette TA, Strain SM, Allen GV, Ryan CL, Tasker RA.

Neurotoxicol Teratol. 2000 Nov-Dec;22(6):863-9.

PMID:
11120392
37.

Microtubule-associated proteins tau and amyloid P component in Alzheimer's disease.

Duong T, Doucette T, Zidenberg NA, Jacobs RW, Scheibel AB.

Brain Res. 1993 Feb 12;603(1):74-86.

PMID:
7680941

Supplemental Content

Loading ...
Support Center